Pfizer $PFE

Pfizer reported its quarterly results yesterday.

Sector : Pharmaceuticals.

Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.

Products : Viagra or the vaccine against COVID-19.

Results :

Revenues : $18.3 billion

Earnings per share : $1.23

Shares of this company are down over 23% so far this year and the dividend is currently around 4%.

However, the stock has been declining lately and the results are not like before. Of course, this stock drop and the lumpy results are due to the fact that a few years ago Pfizer was achieving huge sales and stock growth because of the launch of the COVID-19 vaccine which was used and applied globally.

You can write how you view this company.


Don't have an account? Join us

Log in to Bulios


Sign.popup.orUseEmailAndPassword
Už jsi členem? Přihlásit se

Create Bulios profile

Continue with

Sign.popup.orUseEmailAndPassword
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data and information on thousands of stocks from around the world

Current information from global markets and individual companies

sign.popup.registration.listWhy.fourth

Fair prices, portfolio tracker, stock screener and other tools

Timeline Tracker Overview